(Q35173028)

6 August 2017

1 reference

title

Immune monitoring of human gene therapy trials: potential application to leukemia and lymphoma (English)

1 reference

6 August 2017

0 references

Theresa L Whiteside

1

1 reference

6 August 2017

William Gooding

series ordinal

2

1 reference

6 August 2017

publication date

1 July 2003

1 reference

Blood Cells, Molecules and Diseases

6 August 2017

published in

1 reference

6 August 2017

volume

31

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

63-71

1 reference

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

The role of Fas/FasL in immunosuppression induced by human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-9796%2803%2900064-0

7 January 2021

10.1016/S1079-9796(03)00064-0

Identifiers

DOI

1 reference

6 August 2017

1 reference